HEXO Is on the Move

Investors in Hexo stock should take note of the cannabis firm’s management’s several moves during the past four weeks. 

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors in Hexo (TSX:HEXO)(NYSE:HEXO) stock should take note of the cannabis firm’s several strategic moves made recently. The Canada-based marijuana producer is busy executing its disclosed partnerships-led growth strategy, with several announcements coming out during the past four short weeks. The latest activity could impact valuation, even in the near term.

What has Hexo done recently?

In just four weeks, Hexo has made significant moves on the capital markets and operationally. Here are some of the notable actions management has taken since mid-April.

Capital markets activity

The company filed a $1.2 billion base-shelf prospectus on April 15. The filing signalled management’s serious intention to raise significant sums of capital for growth projects. The payment, on May 3, of $28.9 million to fully repay a syndicated credit facility with Canadian Imperial Bank of Commerce (CIBC) and Bank of Montreal (BMO) reduced leverage and interest risk.

However, the announcement of a $150 million at-the-market (ATM) on May 11 signalled management’s imminent moves on acquisitions and partnerships. The ATM allows the company to sell new shares directly to the public from time to time. The funds will be used to finance the ongoing U.S. expansion program, integrate a recently acquired Zenabis, improve production lines at the flagship Ontario facility, and boost working capital levels.

Operational developments

Hexo launched six new beverages in Canada on April 14. The company is moving to extend its market leadership in the beverages segment through the Truss Beverages partnership with Molson Coors. Consolidating leadership in a growing market segment could make the company a long-term winner. Though at its nascent stages, the cannabis-infused beverages segment could be a huge multi-billion-dollar market. And HEXO is already replicating early success in the United States.

We saw the company announce a brand partnership with REQ, an award-winning digital marketing agency in America on May 13. Hexo is already investing in strongly marketing its brands in the U.S. after recently launching operations in Colorado.

“REQ will evaluate HEXO’s brand presence on- and offline in the U.S. market and evolve the Powered by HEXO  brand in preparation for an exciting period of expansion and growth,” Management explained in a statement on Thursday.

The company made another significant move on Friday, May 14. Hexo announced the acquisition of a 50,000-square-foot manufacturing facility in northern Colorado for an undisclosed amount. The facility is already zoned for the production of “a full range of cannabinoids.” Word is that the U.S. facility is capable of processing non-beverage cannabinoid products, too.

The marijuana producer could just have put together what its undisclosed future U.S.-based partners desire before coming on board its “Powered by HEXO” platform.

Investor takeaway

Although shareholder dilution is a concern, it can be justified by quick execution for growth. The company’s management is moving fast on the operational side. And such quick execution matters; It could justify dilution pains for current shareholders if it produces quick results.

Hexo is putting together all the necessary pieces for its partnerships-led growth strategy into the United States. Management is still silent about who the company’s consumer packaged goods (CPG) partners are. But judging by the speed at which execution is going, something very significant could be in the pipeline.

Although there are still some significant marketing challenges for CBD as far as the U.S. Food and Drug Administration is concerned, partnerships with larger, well-established, and experienced non-beverage CPG firms help the company in navigating hurdles. The company won’t walk alone.

Simply put, here is a Canadian cannabis firm that could give its United States-based competitors a tough game. Hexo stock investors may justifiably expect the firm to be a serious contender in the CBD market tussles in America — more so given its prior success with partnerships in Canada. The company is making some good, purposeful, and well-timed moves before U.S. federal legalization intensifies local competition for capital on the open markets.

Should you invest $1,000 in Alimentation Couche-Tard right now?

Before you buy stock in Alimentation Couche-Tard, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Alimentation Couche-Tard wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »